Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...
Company shares partnership and clinical updates including $7 million Sanofi milestone and more information on patient populations for REC-1245 (RBM39) and REC-617 (CDK7) SALT LAKE CITY, Aug. 05, 2025 ...
Shares of Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) are trading higher after the company, in collaboration with MIT, announced the release of Boltz-2, a new open-source AI model designed to predict ...
Evidently in the mood for some spring cleaning, Salt Lake City’s Recursion is clearing out a chunk of its pipeline as it narrows its focus on R&D in oncology and rare diseases. The move comes roughly ...
Rachael Severino is a writer from New York. She was awarded her Bachelor's in Classical Archaeology and Literature from Sarah Lawrence College. She is currently completing her MFA at Columbia ...
Armed with a combined $850 million in cash, the companies said Thursday the resulting biotech will have a pipeline that could deliver 10 clinical readouts over the next 18 months. The AI-enabled ...
Abstract: Language is the most important supporting tool in communication between humans which aims to convey ideas, thoughts, emotions, feelings or messages to other people. Language can be conveyed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results